The Health Kick Podcast with Tim Boreham
Tim is Stockhead’s resident Health and Biotech expert with his weekly column “Dr Boreham’s Crucible”. Tim was the author of the Criterion column in The Australian newspaper for well over 10 years and has more than three decades’ experience of business reporting across three major publications. In his weekly “The Health Kick Podcast” Tim will interview Australia’s leading Health and Biotech industry leaders, bringing his own unique insight and perspective into the world of health and drug discovery.
Health & Fitness
51
Investor confidence is sky-high in Apiam's dive...
23 min
52
PainChek's AI-backed pain assessment technology...
23 min
53
Investors still high on Incannex's cannabinoid ...
25 min
54
Starpharma goes from strength to strength follo...
19 min
55
Cannpal has first mover advantage in the $67bn ...
24 min
56
Chemo's diminishing role, the 'personalised' ap...
25 min
57
Zelira's cannabis-derived insomnia treatment ha...
22 min
58
Botanix is using synthetic cannabinoids to trea...
24 min
59
Pancreatic cancer treater OncoSil continues imp...
24 min
60
This drug developer is up 200 percent after bei...
20 min
61
VTI has a clear vision for the future of contac...
27 min
62
Cynata's stem cell therapy could be a game chan...
21 min
63
Accurately measuring cognition offers massive u...
27 min
64
Can Aussie drug makers survive COVID-19? And wh...
22 min
65
Chronic kidney disease is a worldwide health cr...
20 min
66
Increasing athletic performance and fighting sl...
24 min
67
Understanding immunotherapy, why the market dri...
20 min
68
Memphasys is using electrical forces on sperm t...
20 min
69
Understanding the strategy and upside behind gl...
20 min
70
Could oral sprays replace pills as a better mea...
20 min
71
The ASX's only medicinal honey player, the mar...
22 min
72
Skyrocketing prescription drug prices, Trump's ...
23 min
73
Coronavirus, HIV and Hepatitis are in the sight...
24 min
74
Novel gene targeting therapies, protein disrupt...
25 min
75
Learning from the Swine flu pandemic, the marke...
20 min